IL10 and melanoma: In mice with melanoma, blockade of A2B receptors reduces IL-10, monocyte chemoattractant protein 1 (MCP-1), and MDSCs in the tumor site, which is associated with increased frequency of intratumoral CD8+ T cells, elevated levels of TNF-α and IFN-γ, and delayed tumor growth (35).